1. Discoidin domain receptor 1 is a potential target correlated with tumor invasion and immune infiltration in gastric cancer
   Songna Wang et al, 2022, Frontiers in Immunology CrossRef
2. Tumor DDR1 deficiency reduces liver metastasis by colon carcinoma and impairs stromal reaction
   Irene Romayor et al, 2021, American Journal of Physiology-Gastrointestinal and Liver Physiology CrossRef
3. Collagen Kinase Receptors as Potential Therapeutic Targets in Metastatic Colon Cancer
   Marie Lafitte et al, 2020, Frontiers in Oncology CrossRef
4. New functions of DDR1 collagen receptor in tumor dormancy, immune exclusion and therapeutic resistance
   Audrey Sirvent et al, 2022, Frontiers in Oncology CrossRef
5. Targeting the Extra-Cellular Matrix—Tumor Cell Crosstalk for Anti-Cancer Therapy: Emerging Alternatives to Integrin Inhibitors
   Girieca Lorusso et al, 2020, Frontiers in Oncology CrossRef
6. Adipose-derived stem cell exosomes promote tumor characterization and immunosuppressive microenvironment in breast cancer
   Qin Zhu et al, 2024, Cancer Immunology, Immunotherapy CrossRef
7. A highly selective humanized DDR1 mAb reverses immune exclusion by disrupting collagen fiber alignment in breast cancer
   Junquan Liu et al, 2023, Journal for ImmunoTherapy of Cancer CrossRef
8. Complex roles of discoidin domain receptor tyrosine kinases in cancer
   V. Mehta et al, 2021, Clinical and Translational Oncology CrossRef
9. Recent Advances in the Role of Discoidin Domain Receptor Tyrosine Kinase 1 and Discoidin Domain Receptor Tyrosine Kinase 2 in Breast and Ovarian Cancer
   Li Chen et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
10. Antibody-drug conjugates targeting DDR1 as a novel strategy for treatment of breast cancer
    Yiran Tao et al, 2024, Journal of Drug Targeting CrossRef